a company, which develops and commercializes DNA base editing technologies for the treatment of human disease.
Industry Biotechnology
A.I.dvisor indicates that over the last year, BEAM has been closely correlated with NTLA. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To BEAM | 1D Price Change % | ||
---|---|---|---|---|
BEAM | 100% | -8.55% | ||
NTLA - BEAM | 74% Closely correlated | -3.65% | ||
CRSP - BEAM | 72% Closely correlated | -4.61% | ||
EDIT - BEAM | 67% Closely correlated | -6.68% | ||
DNLI - BEAM | 66% Closely correlated | +2.78% | ||
PRME - BEAM | 63% Loosely correlated | -9.81% | ||
More |